Conductus ships first supercon probe

Article

Conductus of Sunnyvale, CA, has made the first commercial shipmentof its SuperProtonnmr high-temperature superconducting probefor NMR spectroscopy. The probe, which is being distributed byVarian Associates as part of its Unity Inova spectrometer

Conductus of Sunnyvale, CA, has made the first commercial shipmentof its SuperProtonnmr high-temperature superconducting probefor NMR spectroscopy. The probe, which is being distributed byVarian Associates as part of its Unity Inova spectrometer system,was shipped to the National High Magnetic Field Lab at FloridaState University in Tallahassee.

SuperProtonnmr uses coils made of the high-temperaturesuperconductor yttrium barium copper oxide (SCAN 4/24/96). Conductusclaims that the probe is four times as sensitive as conventionalNMR probes, allowing the analysis of much smaller samples.

In other Conductus news, the company this month announced adistribution agreement with Nalorac, a Martinez, CA, manufacturerand distributor of NMR probes. The deal will expand the distributioncoverage available for Conductus' high-temperature superconductingprobes, as Nalorac supplies conventional NMR probes to all majorNMR manufacturers.

Recent Videos
Improving Access to Nuclear Imaging: An Interview with SNMMI President Jean-Luc C. Urbain, MD, PhD
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Related Content
© 2025 MJH Life Sciences

All rights reserved.